Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice

Endocrinology

Volumn 137, Issue 10, 1996, Pages 4210-4216

  Kumar, T Rajendra ^a   Wang, Yan ^a   Matzuk, Martin M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; INHIBIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CACHEXIA; CANCER INHIBITION; MOUSE; NONHUMAN; OVARY TUMOR; PENETRANCE; PRIORITY JOURNAL; SEX CORD TUMOR; TESTIS TUMOR; TUMOR GROWTH;

EID: 0029742472     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.10.8828479     Document Type: Article

References (27)

1. Damjanov I 1993 Pathology of Infertility. Mosby, St. Louis, pp 1-42
2. Marchbanks PA, Peterson HB, Rubin GL, Wingo PA 1989 Cancer and Steroid Hormone Study Group. Research on infertility: definition makes a difference. Am J Epidemiol 130:259-267
3. Vale W, Bilezikjian LM, Rivier C 1994 Reproductive and other roles of inhibins and activins. In: Knobil E, Neill JD (eds) The Physiology of Reproduction. Raven Press, New York, pp 1861-1878
4. Matzuk MM, Finegold MJ, Su J-GJ, Hsueh AJW, Bradley A 1992 α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313-319
5. Matzuk MM, Kumar TR, Shou WS, Coerver KA, Lau AL, Behringer RR, Finegold MJ 1996 Transgenic models to study the roles of inhibins and activins in reproduction, development and oncogenesis. Recent Prog Horm Res 51:123-157
6. Matzuk MM, Finegold MJ, Mishina Y, Bradley A, Behringer RR 1995 Synergistic effects of inhibins and Müllerian-inhibiting substance on testicular tumorigenesis. Mol Endocrinol 9:1337-1345
7. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H, Bradley A 1994 Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA 91:8817-8821
8. Bousfield GR, Perry WM, Ward DN 1994 Gonadotropins: chemistry and biosynthesis. In: Knobil E, Neill JD (eds) The Physiology of Reproduction. Raven Press, New York, pp 1749-1792
9. Gharib SD, Wierman ME, Shupnik MA, Chin WW 1990 Molecular biology of the pituitary gonadotropins. Endocr Rev 11:177-199
10. Tapanainen JS, Tilly JL, Vihko KK, Hsueh AJW 1993 Hormonal control of apoptotic cell death in the testis: gonadotropins and androgens as testicular cell survival factors. Mol Endocrinol 7:643-650
11. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH 1995 Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA 92:1322-1326
12. Godwin AK, Perez RP, Johnson SW, Hamaguchi K, Hamilton TC 1992 Growth regulation of ovarian cancer. Hematol Oncol Clin North Am 6:829-841
13. Tennent BJ, Shultz KL, Beamer WG 1993 Genetic susceptibility for C19 androgen induction of ovarian granulosa cell tumorigenesis in swxj strains of mice. Cancer Res 53:1059-1063
14. Beamer WG, Shultz KL, Tennent BJ, Shultz LD 1993 Granulosa cell tumor-igenesis in genetically hypogonadal-immunodeficient mice grafted with ovaries from tumor-susceptible donors. Cancer Res 53:3741-3746
15. Mason AJ, Hayflick JS, Zoeller RT, Young III WS, Phillips HS, Nikolics K, Seeburg PH 1986 A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 234:1366-1371
16. Kumar TR, Low MJ 1995 Hormonal regulation of human follicle-stimulating hormone-β subunit gene expression: GnRH stimulation and GnRH- independent androgen inhibition. Neuroendocrinology 61:628-637
17. Simon WE, Albrecht M, Hänsel M, Dietel M, Hölzel F 1983 Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst 70:835-845
18. Simon WE, Hölzel F 1979 Hormone sensitivity of gynecological tumor cells in tissue cultures. J Cancer Res Clin Oncol 94:307-323
19. Neumann F 1991 Early indicators for carcinogenesis in sex-hormone-sensitive organs. Mutat Res 248:341-356
20. Wimalasena J, Dostal R, Meehan D 1992 Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth. Gynecol Oncol 46:345-350
21. Pescovitz OH, Srivastava CH, Breyer PR, Monts BA 1994 Paracrine control of spermatogenesis. Trends Endocrinol Metab 5:126-131
22. Parmer H, Phillips RH, Lightman SL, Schally AV 1988 Therapy of advanced ovarian cancer with D-Trp-6-LH-RH (decapeptyl) microcapsules. Biomed Pharmacother 42:531-538
23. Slotman BJ, Rao BR 1989 Response to inhibition of androgen action of human ovarian cancer cells in vitro. Cancer Lett 45:213-220
24. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90:11162-11166
25. Paquis-Flucklinger V, Michiels J-F, Vidal F, Alquier C, Pointis G Bourdon V, Cuzin F, Rassoulzadegan M 1993 Expression in transgenic mice of the large T antigen of polyoma virus induces Sertoli cell tumors and allows the establishment of differentiated cell lines. Oncogene 8:2087-2094
26. Paquis-Flucklinger V, Rassoulzadegan M, Michiels J-F 1994 Experimental Sertoli cell tumors in the mouse and their progression into a mixed germ cell-sex cord proliferation. Am J Pathol 144:454-459
27. Peschon JJ, Behringer RR, Cate RL, Harwood KA, Idzerda RL, Brinster RL, Palmiter RD 1992 Directed expression of an oncogene to Sertoli cells in transgenic mice using Müllerian inhibiting substance regulatory sequences. Mol Endocrinol 6:1403-1411